Efficacy and Safety of Lenalidomide, PD-1 Monoclonal Antibodies Combined with Orelabrutinib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase II Study

被引:0
|
作者
Wang, Lingling [1 ]
Huang, Yongfen [1 ]
Chen, Hui [1 ]
Xu, Hao [1 ]
Cheng, Yuexin [1 ]
Miao, Yuqing [1 ]
机构
[1] Xuzhou Med Univ, Peoples Hosp Yancheng 1, Yancheng Clin Coll, Dept Hematol, Yancheng, Peoples R China
关键词
D O I
10.1182/blood-2024-198309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:6488 / 6489
页数:2
相关论文
共 50 条
  • [21] Efficacy and Safety of PD-1 Inhibitor Plus Rituximab in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Qin, Yan
    He, Xiaohui
    Yang, Sheng
    Liu, Peng
    Zhou, Shengyu
    Yang, Jianliang
    Gui, Lin
    Zhong, Qiaofeng
    Zhao, Fengyi
    Shi, Yuankai
    Jing, Hongmei
    Zhang, Shiyue
    Guo, Ruihan
    Shi, Yuankai
    BLOOD, 2021, 138
  • [22] Open-Label, Single-Arm, Phase II Study of Everolimus in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
    Johnston, Patrick B.
    Pinter-Brown, Lauren
    Rogerio, Jaqueline
    Warsi, Ghulam
    Graham, Anne
    Ramchandren, Radhakrishnan
    BLOOD, 2011, 118 (21) : 1169 - 1169
  • [23] A Multicenter Open-Label, Phase 1b/2 Study of Ibrutinib in Combination with Lenalidomide and Rituximab in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Goy, Andre
    Ramchandren, Radhakrishnan
    Ghosh, Nilanjan
    Munoz, Javier
    Morgan, David S.
    Dang, Nam H.
    Knapp, Mark
    Delioukina, Maria
    Kingsley, Edwin C.
    Anh Tran
    Ping, Jerry
    Beaupre, Darrin M.
    Neuenburg, Jutta K.
    Ruan, Jia
    BLOOD, 2016, 128 (22)
  • [24] An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma
    Morschhauser, Franck
    Salles, Gilles
    Le Gouill, Steven
    Tilly, Herve
    Thieblemont, Catherine
    Bouabdallah, Krimo
    Fabiani, Bettina
    Menard, Cedric
    Tarte, Karin
    Cartron, Guillaume
    Houot, Roch
    BLOOD, 2018, 132 (14) : 1486 - 1494
  • [25] Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients
    Qin, Yan
    He, Xiaohui
    Chen, Xinrui
    Xie, Zucheng
    Yang, Jianliang
    Yang, Sheng
    Liu, Peng
    Zhou, Shengyu
    Zhang, Changgong
    Gui, Lin
    Shi, Yuankai
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (03) : 356 - 364
  • [26] PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma
    Ping, Liqin
    Gao, Yan
    He, Yanxia
    Bai, Bing
    Huang, Cheng
    Shi, Lina
    Wang, Xiaoxiao
    Huang, Huiqiang
    ANNALS OF HEMATOLOGY, 2023, 102 (08) : 2189 - 2198
  • [27] PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma
    Liqin Ping
    Yan Gao
    Yanxia He
    Bing Bai
    Cheng Huang
    Lina Shi
    Xiaoxiao Wang
    Huiqiang Huang
    Annals of Hematology, 2023, 102 : 2189 - 2198
  • [28] Safety of chidamide plus rituximab in elderly patients with relapsed or refractory B-cell lymphoma in China: a multicenter, single-arm, phase II study
    Chen, Xinrui
    Wang, Huaqing
    Sun, Xiuhua
    Su, Liping
    Liu, Fengting
    Zhao, Ke
    Xu, Liye
    Wu, Shaohua
    Song, Teng
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (24)
  • [29] Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial
    Jerkeman, Mats
    Eskelund, Christian Winther
    Hutchings, Martin
    Raty, Riikka
    Wader, Karin Fahl
    Laurell, Anna
    Toldbod, Helle
    Pedersen, Lone Bredo
    Niemann, Carsten Utoft
    Dahl, Christina
    Kuitunen, Hanne
    Geisler, Christian H.
    Gronbaek, Kirsten
    Kolstad, Arne
    LANCET HAEMATOLOGY, 2018, 5 (03): : E109 - E116
  • [30] Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia
    O'Brien, Maureen M.
    Alonzo, Todd A.
    Cooper, Todd M.
    Levine, John E.
    Brown, Patrick A.
    Slone, Tamra
    August, Keith J.
    Benettaib, Bouchra
    Biserna, Noha
    Poon, Jennifer
    Patturajan, Meera
    Chen, Nianhang
    Simcock, Mathew
    Zimmerman, Linda
    Kolb, E. Anders
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)